U.S. President Donald Trump ended days of rumors and speculation when he confirmed May 12 that Marty Makary is resigning as FDA commissioner. Speaking with reporters before heading off to China for a ...

In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early development programs in the fields of ...

The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a ...

Bright Uro Inc. secured U.S. FDA 510(k) clearance for the Glean abdominal sensor, which expands the capabilities of its Glean urodynamics system to enable multichannel urodynamic studies. The new ...

Seven years, almost to the day, after releasing a draft guidance on post-approval pregnancy safety studies, the U.S. FDA is now finalizing it – albeit with a few changes.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Amplitude Vascular Systems, Assertio, Capricor, Garda, GSK, Merck, Nippon, Stryker.

Roche Holding AG has agreed to acquire Pathai Inc. for up to $1.05 billion in a bid to strengthen its position in digital ...

Infectious disease-focused biopharma stocks, tracked on the BioWorld Infectious Disease Index (BIDI), saw their collective ...

Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the ...

Mobia Medical Inc. began trading on Nasdaq under the ticker MOBI on May 8. The company priced its IPO at the midpoint of its ...

In a deal that could be worth up to $1 billion for Suzhou Siran Biotechnology Co. Ltd. (Siranbio), GSK plc licensed exclusive ...

Raising $279 million in an IPO and another $25 million in a concurrent private placement, Odyssey Therapeutics Inc. is ...